52Colorectal cancer (CRC) is one of the most common cancers in China. In 2003, a systematic CRC 53 registry that enables the determination of CRC incidence and mortality and a CRC screening project 54 were introduced in the Jing'an district of Shanghai by the municipal government. This study assessed 55 the registry data to determine the status of CRC and CRC screening rates in the core district of an 56 urban area of China. Data were retrieved from the Official registry information systems of Jing'an 57 district Shanghai Cance. The incidence and mortality of CRC, as well as population-based CRC 58 screening rates, were analysed. Individuals who screened positive for CRC based upon results of a 59 high-risk factor questionnaire (HRFQ) and a faecal immunochemical test (FIT) were selected for 60 follow-up colonoscopy (CSPY). From the registry data collected between 2003 and 2013, the 61 standardized incidence rate was 26.44/10 5 , with a significant gender difference. The CRC 62 standardized mortality rate was 10.08/10 5 . In 2013, 17,866 individuals (21.6%) enrolled for CRC 63 screening among the 82,602 candidate residents. The positive screening rate was 16.28%
64(2909/17866). Among the 2909 positives, 508 (17.5%) underwent follow-up CSPY. In 41.3% of 65 these individuals (210/508), abnormal lesions were detected. Of these, 8 (1.57%) lesions were 66 diagnosed as CRC, and 142 (28.0%) were identified as precancerous lesions. During the assessment 67 period, both the incidence and mortality of CRC in the Jing'an district were determined in the area of 68 high CRC prevalence in Chin. Nevertheless, the rate of participation in CRC screening was low 69 (21.6%), and the rate of participation in follow-up CSPY for individuals who screened positive was 70 only 17.5%. Improved participation in CRC screening and follow-up CSPY is expected to lower the 71 incidence and mortality of CRC significantly in the rural areas of China. (288) 72 73 74 75 76 77 78 79 80 4 81 82 131 CDC (Shanghai Jingan Center for Disease Control and Prevention), through the Shanghai Cancer 132 Registry Information System and the Shanghai All Causes of Death Registration Reporting System 133 organized by the Shanghai Government and Jingan municipal office. 134 135 The CRC screening was conducted by six sites of the community health service center in this district 136 under supervise by the health bureau of the Shanghai Government and Jingan municipal office. 137 Colonoscopy and the follow-up diagnosis for further treatment under supervise by the health bureau 138 were performed in the four designated hospitals (Jing'an District Central hospital, Huashan hospital, 139 Huadong hospital and Post & Telecommunications Hospital of Shanghai.).140 307 assessment and development of other assessments are in progress[24-29], the FIT used in this study 308 appears reliable and appropriate for CRC screening at this stage.309 310 Follow-up colonoscopy (CSPY) is indispensable for reducing CRC mortality in individuals who 311 screen positive for CRC 312 CSPY is c...